Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| cancer detecter prostate |
|
BBC News | HEALTH | Microchip able to detect cancer Scientists have developed a microscopic device to detect the first signs of prostate cancer. They believe it could also be used to detect other diseases. Prostate Cancer Clinical Studies The research showed that fPSA does in fact improve the accuracy of total PSA for detecting prostate cancer, while cPSA does not. cPSA did not detect any The Journal of Urology : Detection of Prostate Cancer Using Serum 1 The lack of specificity of PSA to detect prostate cancer results in subjecting men to unnecessary biopsies as well as considerable anxiety. Radioguided Sentinel Lymph Node Dissection in Staging of Prostate Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of FCH PET/CT and laparoscopic PSA Test Still Important To Detect Prostate Cancer, New Studies Statins also may help reduce risk of getting the disease. USRF - PCA3: A Genetic Marker of Prostate Cancer Thompson, in data from the Prostate Cancer Prevention Trial, where biopsies were .. a new molecular urine test for the detection of prostate cancer. Tactile Sensor System for Detection of Prostate Cancer and Hypertrophy Tactile Sensor System for Detection of Prostate Cancer. and Hypertrophy. Mami Tanaka, Cho Ji-Young and Seiji Chonan. Yoshikatsu Tanahashi The Detection of Bone Metastases in Patients with High-Risk F-Fluoride PET/CT in detection of bone metastases in. prostate cancer patients with high-risk for bone metastases. MATERIALS AND METHODS. Patients Researchers Discover Protein Signatures for Prostate Cancer That "In this study, we took advantage of the body's own immune system as a detector of prostate cancer,Á« said Arul Chinnaiyan, M.D., Ph.D., study leader, IngentaConnect Diagnostic Methods in the Detection of Prostate Diagnostic Methods in the Detection of Prostate Cancer: Prospective Observational Study. Authors: Lopez-Saez, Juan-Bosco1; Otero, Milagros1; Cancer Tests PSA - Prostate Specific Antigen PSA - Prostate Specific Antigen may help detect prostate cancer early. PSA (prostate specific antigen) is a substance made Method of detection of prostate cancer - Patent 7252935 The present invention provides methods and kits useful for detecting neplasia by measuring the methylation level of biomarkers, especially the promoter National Prostate Cancer Coalition (NPCC) Progress Seen in Prostate Cancer Gene Tests Reuters | 04.06.2006. New Cancer Detector Developed That's Fast, Sensitive, Reliable Harvard Gazette: New cancer detector developed that's fast Monitoring cancer. The disease detector works on a simple principle. prostate specific antigen (PSA), a well-known herald of prostate cancer, Cancer Detector LEC-03C The Cancer Detector LEC-03C is claimed to measure the speed with which of the breast and colon 5, basal cell carcinoma 6, prostate cancer 7, PSA Test Still Important for Prostate Cancer - Cancer Information PSA Test Still Important to Detect Prostate Cancer, Studies Find. By Steven Reinberg HealthDay Reporter. SUNDAY, May 20 (HealthDay News) -- Despite NEJM -- Autoantibody Signatures in Prostate Cancer Background New biomarkers, such as autoantibody signatures, may improve the early detection of prostate cancer. Methods With a phage-display library derived Prostate Cancer Test Works Well for Black Men "Because early detection is currently our best hope against prostate cancer," says Partin, "it's crucial that we can rely on effective screening tools like cancer prostate Le meilleur gage de guö©rison est donc de dö©tecter le cancer ö un stade prö©coce, quand il est encore localisö© ö la prostate, sans extension en dehors d'elle. |
| cancer detecter prostate |
|
erection exam nurse prostate alternative cancer medicine more prostate 2b cancer mortality prostate cryosurgery prostate cancer |